Login
Navigate Fool.com
Will HPTX beat
the market?

Hyperion Therapeutics

NASDAQ: HPTX

Community Rating: 1 Star: Ominous

25.61 -0.67 (-2.55%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $26.27
Previous Close $26.28
Daily Range $25.32 - $26.27
52-Week Range $15.92 - $32.98
Market Cap $516.8M
P/E Ratio 32.85
Dividend (Yield) $0.00 (0.0%)
Volume 57,326
Average Daily Volume 92,868
Current FY EPS $0.12

How do you think HPTX
will perform against the market?

Top HPTX Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

This Week in Biotech: 2 FDA Approvals and 3 Clinically Impressive Studies

Two biopharma stocks bask in an FDA approval while three others head higher following positive clinical data -- including a triple-digit percent gainer!

Wednesday Sector Leaders: Drugs, Biotechnology Stocks

Why Hyperion Therapeutics Inc. Shares Popped

Shares of Hyperion jumped after publishing successful midstage results for a key drug in the March issue of Hepatology. Should investors welcome this news with open arms or be cautious moving forward?

Biotech booms on Wall Street

Why Hyperion Therapeutics Inc. Shares Roared Higher

Hyperion shares spike after the company reports third-quarter earnings results. Can the stock continue to head higher or could it be time to bail?

Sector Update: Healthcare Shares Higher Pre-Market; Lexicon Surges 21% on Glucose Inhibitor's Succes

Sector Update: Healthcare Shares Higher Pre-Market; Lexicon Surges 21% on Glucose Inhibitor's Success

Sector Update: Healthcare

Why Hyperion Therapeutics Shares Shot Higher

A favorable drug status, and the addition of two new urea cycle drugs, excites Hyperion shareholders.

3 Stocks to Get on Your Watchlist

Are these three stocks about to make a large move?

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

See More HPTX News...

Sector

Healthcare

Industry

Drugs

Hyperion Therapeutics (HPTX) Description

Hyperion Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. Website: http://www.hyperiontx.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks